News | Vascular Access | September 20, 2016

Teleflex Promotes Rise of the Vascular Access Specialist at AVA 2016 Congress

Company features new online clinical education platform, hosts several symposia on vascular access technology

Teleflex, AVA 2016 Congress, Association for Vascular Access

September 20, 2016 — Teleflex Inc. recently displayed its vascular access technologies and a new educational platform focused on the rise of the vascular access specialist at the 30th Annual Scientific Meeting of the Association for Vascular Access (AVA). The meeting was held Sept. 16-19 in Orlando, Fla.

Teleflex unveiled the Teleflex Academy, a new online clinical education platform. The booth educational experience for the Teleflex Academy at this year’s AVA focused on every aspect of vascular access. Teleflex believes that quality education is the first step in fostering the expansion of skills and helping to shape clinical practice.

Teleflex also launched the Arrow Midline with Chlorag+ard Technology, adding to the family of antithrombogenic and antimicrobial protected catheters.

The company offered its popular Vascular Access Procedural Cadaver Lab onsite, training on many different vascular access procedures. There were also clinical education activities at its booth, where models were used to demonstrate the full range of the company’s vascular access devices.

At the breakfast symposium, “Rising to the Challenge: How Vascular Access Specialists Started Placing CVCs,” attendees were educated on the importance of the evolution of the vascular access specialist. This course highlighted the experiences of clinicians who have made the journey to expand their roles to place central venous catheters, and described the clinical process and materials needed to develop a vascular access team.

The platinum showcase symposium, “Locking the Lumen…Consider the Solutions!” reviewed why given today’s medical reimbursement risks, facilities must explore all opportunities to reduce potential vascular access complications. Locking solutions could provide an additional layer of protection when used in conjunction with proven protected catheter technology. The presentation addressed catheter colonization, intraluminal colonization, and how locking solutions and protected catheters address these.

The dinner symposium, “Strategy or Risk: the Use of Midline Catheters”, focused on the recent popularity of Midline catheters, the role of a Midline, and how technology could be the key to ensuring Midline success.

For more information: www.teleflex.com

Related Content

Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
Overlay Init